MétaCan
Menu
Back to cohort
Record W4391219445 · doi:10.1016/j.ccell.2024.01.001

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

2024· article· en· W4391219445 on OpenAlexfundno aff
Simon Heeke, Carl M. Gay, Marcos R. Estecio, Hai T. Tran, Benjamin B. Morris, Bingnan Zhang, Ximing Tang, Maria Gabriela Raso, Pedro Rocha, Siqi Lai, Edurne Arriola, Paul Hofman, Véronique Hofman, Prasad Kopparapu, Christine M. Lovly, Kyle Concannon, Luana Guimarães de Sousa, Whitney E. Lewis, Kimie Kondo, Xin Hu, Azusa Tanimoto, Natalie I. Vokes, Monique B. Nilsson, Allison Stewart, M. Jansen, Ildikó Horváth, Mina Gaga, Vasileios Panagoulias, Yael Raviv, Danny Frumkin, Adam Wasserstrom, Aharona Shuali, Catherine A. Schnabel, Yuanxin Xi, Lixia Diao, Qi Wang, Jianjun Zhang, Peter Van Loo, Jing Wang, Ignacio I. Wistuba, Lauren A. Byers, John V. Heymach

Bibliographic record

VenueCancer Cell · 2024
Typearticle
Languageen
FieldMedicine
TopicLung Cancer Research Studies
Canadian institutionsnot available
FundersHorizon 2020Daiichi Sankyo EuropeNational Cancer InstituteHORIZON EUROPE Framework ProgrammeUniversity of Texas MD Anderson Cancer CenterEMD SeronoFoundation MedicineSierra OncologySociedad Española de Oncología MédicaBirla Institute of Scientific ResearchPharmaMarEuropean Society for Medical OncologyRexanna's FoundationBeiGeneMirati TherapeuticsPfizerInnovent BiologicsMedical Research CouncilLes Laboratories Pierre FabreJazz PharmaceuticalsFrancis Crick InstituteNational Institutes of HealthRegeneron PharmaceuticalsCancer MoonshotAlbert Einstein Cancer CenterGenentechCancer Prevention and Research Institute of TexasMoonshot Research and Development ProgramSanofiGlaxoSmithKlineBristol-Myers SquibbEli Lilly and CompanyAstraZenecaWellcome TrustCancer Research UKSpectrum PharmaceuticalsAmgenAgence Nationale de la RechercheLUNGevity Foundation
KeywordsSubtypingDNA methylationEpigeneticsBiologyLung cancerMalignancyCancer researchMethylationOncologyGeneMedicineGene expressionGenetics

Abstract

fetched live from OpenAlex

Small cell lung cancer (SCLC) is an aggressive malignancy composed of distinct transcriptional subtypes, but implementing subtyping in the clinic has remained challenging, particularly due to limited tissue availability. Given the known epigenetic regulation of critical SCLC transcriptional programs, we hypothesized that subtype-specific patterns of DNA methylation could be detected in tumor or blood from SCLC patients. Using genomic-wide reduced-representation bisulfite sequencing (RRBS) in two cohorts totaling 179 SCLC patients and using machine learning approaches, we report a highly accurate DNA methylation-based classifier (SCLC-DMC) that can distinguish SCLC subtypes. We further adjust the classifier for circulating-free DNA (cfDNA) to subtype SCLC from plasma. Using the cfDNA classifier (cfDMC), we demonstrate that SCLC phenotypes can evolve during disease progression, highlighting the need for longitudinal tracking of SCLC during clinical treatment. These data establish that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.363
Teacher spread0.333 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations112
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueCancer CellSame topicLung Cancer Research StudiesFrench-language works237,207